Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada
Open Access
- 7 October 2023
- Vol. 41 (46) , 6802-6809
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic ThrombocytopeniaNew England Journal of Medicine, 2021
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 VaccinationNew England Journal of Medicine, 2021
- Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not knowBlood, 2021
- Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the ManufacturerNew England Journal of Medicine, 2021
- Thrombotic Thrombocytopenia after Ad26.COV2.S VaccinationNew England Journal of Medicine, 2021
- Development of a high-yield expression and purification system for platelet factor 4Platelets, 2017
- Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson DataMethodology and Computing in Applied Probability, 2017
- Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopeniaJournal of Thrombosis and Haemostasis, 2015
- A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety SurveillanceSequential Analysis, 2011
- A diagnostic test for heparin-induced thrombocytopeniaBlood, 1986